ArticleEndocrine2025
Assessing the role of the Triglyceride-glucose related indices in identifying metabolic syndrome risk across body mass index categories.
Article in Endocrine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
purposeThis study aimed to explore the association between triglyceride-glucose (TyG) related indices and the metabolic syndrome (MetS).
methodsA cross-sectional study was conducted involving 10,431 individuals who participated the medical examination for the elderly in 2023 at Shanghai Jiading Nanxiang Community Health Service Center. We compared 4 indicators, TyG, TyG-body mass index (TyG-BMI), TyG-waist circumference (TyG-WC), and metabolic score for insulin resistance (MetS-IR) — to assess their ability to predict MetS. Logistic regression analysis and subgroup analysis were performed to investigate the relationship between these four indices and the risk of MetS in normal weight, overweight and obese group. And we conducted the receiver operating characteristic curves (ROC) to definite predictive utility for identifying MetS in the elderly individuals across diverse BMI groups.
resultsIn this study, all the studied markers were significantly associated with MetS. TyG showed the highest area under the curve (AUC) for identifying MetS across different BMI groups (AUC = 0.855–0.903), indicating its discriminative ability for predicting MetS. Additionally, significant interactions were observed between the biomarkers and MetS across different subgroups adjusted by confounders, which suggested that TyG and MetS-IR showed stronger associations with MetS in females than in males. Meanwhile, BMI stratification demonstrated that TyG showed highest OR in obese group (OR = 10.55) while MetS-IR (OR = 11.93) performed better in normal weight group.
conclusionThese results suggested that the TyG index and its related markers are valuable tools for predicting MetS across different BMI categories in a large community-based population, with particularly high utility observed in older adults and individuals with obesity.
Indexed as
Identifiers
41460418What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.